New York State Common Retirement Fund
OTLK icon

New York State Common Retirement Fund’s Outlook Therapeutics OTLK Stock Holding History

New York State Common Retirement Fund’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,821
Closed -$2.22K – 3301
2025
Q1 		$2.22K Hold
1,821
– – ﹤0.01% 3152
2024
Q4 		$3.44K Hold
1,821
– – ﹤0.01% 3153
2024
Q3 		$9.72K Hold
1,821
– – ﹤0.01% 3111
2024
Q2 		$13.4K Buy
1,821
+8
+0.4% +$64 ﹤0.01% 3230
2024
Q1 		$21.6K Hold
1,813
– – ﹤0.01% 3135
2023
Q4 		$14.3K Sell
1,813
-18
-1% -$152 ﹤0.01% 3176
2023
Q3 		$8.09K Buy
1,831
+21
+1% +$465 ﹤0.01% 3228
2023
Q2 		$63K Buy
1,810
+14
+0.8% +$382 ﹤0.01% 3084
2023
Q1 		$39.2K Hold
1,796
– – ﹤0.01% 3045
2022
Q4 		$38.8K Sell
1,796
-8
-0.4% -$174 ﹤0.01% 3125
2022
Q3 		$44K Buy
1,804
+15
+0.8% +$349 ﹤0.01% 3155
2022
Q2 		$36K Buy
1,789
+2
+0.1% +$57 ﹤0.01% 3241
2022
Q1 		$64K Hold
1,787
– – ﹤0.01% 3118
2021
Q4 		$49K Sell
1,787
-7
-0.4% -$250 ﹤0.01% 3222
2021
Q3 		$78K Sell
1,794
-1,956
-52% -$94.4K ﹤0.01% 3189
2021
Q2 		$187K Buy
+3,750
New +$174K ﹤0.01% 3067

Other funds holding OTLK

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

New York State Common Retirement Fund's OTLK Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Outlook Therapeutics (OTLK) in Q2 2025, closing a stake of 1,821 shares — an estimated $2.22K sold.

New York State Common Retirement Fund first reported a position in OTLK in Q2 2021 and held it in 16 quarters. The position peaked at $187K in Q2 2021. 66 funds tracked by Wall St. Rank hold OTLK as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Outlook Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,821 Outlook Therapeutics shares in Q2 2025, an estimated $2.22K.
  • New York State Common Retirement Fund first reported a position in Outlook Therapeutics in Q2 2021 and held it in 16 quarters.
  • New York State Common Retirement Fund's Outlook Therapeutics position peaked at $187K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.